Consistent with these publications, we demonstrated that PGC-1α is an obligatory downstream effector of PRMT1 that mediate hepatic FAO capacity and subsequent protective effects of overexpressing PRMT1 against HFD-induced steatosis. The gene discussed is PRMT1; the disease is steatosis.